# Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk

Study · id `cardio:ct-nct07067658` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07067658](<https://clinicaltrials.gov/study/NCT07067658>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07067658

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT07067658. Randomized; quadruple masking; primary purpose prevention. Start 2025-12-18 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT07067658, source copy `cardio:ctgov-nct07067658-2026-07-28`, retrieved 2026-10-26)
- Started: 2025-12-18 (actual) (ClinicalTrials.gov record NCT07067658, source copy `cardio:ctgov-nct07067658-2026-07-28`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT07067658, source copy `cardio:ctgov-nct07067658-2026-07-28`, retrieved 2026-10-26)
- Completion: 2027-07-31 (anticipated) (ClinicalTrials.gov record NCT07067658, source copy `cardio:ctgov-nct07067658-2026-07-28`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT07067658, source copy `cardio:ctgov-nct07067658-2026-07-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07067658-2026-07-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk
- Acronym: ME-HF
- Condition: Heart Failure
- Intervention (Device): Installation of Heartfelt Device
- Intervention (Other): Enhanced Standard care
- Intervention (Other): Questionnaires
- Intervention (Device): Heartfelt device alerting system
- Lead sponsor: Heartfelt Technologies
- Lead sponsor class: INDUSTRY
- Collaborator: Manchester University NHS Foundation Trust
- Collaborator class: OTHER\_GOV
- Collaborator: University of Glasgow
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Heartfelt Technologies (`cardio:org-heartfelt-technologies`)
- Registry lists this organization as a collaborator: Manchester University NHS Foundation Trust (`cardio:org-manchester-university-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)

## Provenance

Content hash: 9d47e81799278d117e2137ca22209151902237a048c226ec25d80403bc00c0b8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
